T A B L E O F C O N T E N T S

Main results
We included two studies, with a total of 64 randomised participants (50 and 14 participants) aged 18 years or over, with a perianal abscess. In both studies, participants were enrolled on the first post-operative day and randomised to continued packing by community district nursing teams or to no packing. Participants in the non-packing group managed their own wounds in the community and used absorbant dressings to cover the area. Fortnightly follow-up was undertaken until the cavity closed and the skin re-epithelialised, which constituted healing. For non-attenders, telephone follow-up was conducted.
Both studies were at high risk of bias due to risk of attrition, performance and detection bias.
It was not possible to pool the two studies for the outcome of time to healing. It is unclear whether continued post-operative packing of the cavity of perianal abscesses affects time to complete healing. One study reported a mean time to wound healing of 26.8 days (95% confidence interval (CI) 22.7 to 30.7) in the packing group and 19.5 days (95% CI 13.6 to 25.4) in the non-packing group (it was not clear if all participants healed). We re-analysed the data and found no clear difference in the time to healing (7.30 days longer in the packing group, 95% CI -2.24 to 16.84; 14 participants). This was assessed as very low quality evidence (downgraded three levels for very serious imprecision and serious risk of bias). The second study reported a median time to complete wound healing of 24.5 days (range 10 to 150 days) in the packing group and 21 days (range 8 to 90 days) in the non-packed group. There was insufficient information to be able to recreate the analysis and the original analysis was inappropriate (did not account for censoring). This second study also provided very low quality evidence (downgraded four levels for serious risk of bias, serious indirectness and very serious imprecision).
There was very low quality evidence (downgraded for risk of bias, indirectness and imprecision) of no difference in wound pain scores at the initial dressing change. Both studies also reported patients' retrospective judgement of wound pain over the preceding two weeks (visual analogue scale, VAS) as lower for the non-packed group (2; both studies) compared with the packed group (0; both studies); (very low quality evidence) but we have been unable to reproduce these analyses as no variance data were published.
There was no clear evidence of a difference in the number of post-operative fistulae detected between the packed and non-packed groups (risk ratio (RR) 2.31, 95% CIs 0.56 to 9.45, I 2 = 0%) (very low quality evidence downgraded three levels for very serious imprecision and serious risk of bias).
There was no clear evidence of a difference in the number of abscess recurrences between the packed and non-packed groups over the variable follow-up periods (RR 0.72, 95% CI 0.22 to 2.37, I 2 = 0%) (very low quality evidence downgraded three levels for serious risk of bias and very serious imprecision).
No study reported participant health-related quality of life/health status, incontinence rates, time to return to work or normal function, resource use in terms of number of dressing changes or visits to a nurse, or change in wound size.
Authors' conclusions
It is unclear whether using internal dressings (packing) for the healing of perianal abscess cavities influences time to healing, wound pain, development of fistulae, abscess recurrence or other outcomes. Despite this absence of evidence, the practice of packing abscess cavities is commonplace. Given the lack of high quality evidence, decisions to pack may be based on local practices or patient preferences. Further clinical research is needed to assess the effects and patient experience of packing.
P L A I N L A N G U A G E S U M M A R Y
Internal dressings for healing perianal abscess cavities
What are perianal abscesses and how are they treated?
A perianal abscess is a collection of pus under the skin around the anus (back passage); perianal abscesses are common, and usually due to an infection in an anal gland. In the UK, the standard treatment is to have an operation under anaesthetic to cut the skin and drain the pus. This prevents the infection spreading and relieves pain in the affected area. An internal dressing (otherwise known as a "pack") is placed inside the abscess cavity, initially to stop bleeding. The pack is changed by nurses in the community regularly until the cavity has healed. It is thought that packing the cavity reduces the chance of the abscess recurring.
Some patients go on to develop a fistula after a perianal abscess. A fistula is an abnormal communication between the anus and the skin next to it and a small hole next to the anus discharges pus intermittently. Fistulae can take many months and several operations to heal. This review aims to assess the effects of packs on healing perianal abscess cavities, particularly the time it took for the cavities to heal, and the amount of pain patients experienced.
What we found
After extensive searching to find relevant studies, we found only two randomised controlled trials (RCTs) that were eligible for this review (RCTs provide more robust results than other trial types). The studies were small with a total of 64 participants randomised, all over 18 years of age, with a perianal abscess. In the studies, participants received either packing by community nursing teams or no packing. Participants in the non-packing group managed their own wounds by using absorbant dressings to cover the area with no internal dressing. Participants were seen fortnightly until the cavity had healed.
It is not clear whether time to complete wound healing is affected by packing of cavity (and what evidence exists is very low quality). There was very low quality evidence that packing made no difference to wound pain at the first dressing change. There was very low quality evidence that on judging the wound pain over the preceding two weeks, participants in the packing group had experienced more pain that those in the non-packing group.
It is not clear whether packing or not affects the number of post-operative fistulae or abscess recurrences.
We did not find any RCTs that compared participant health-related quality of life/health status, incontinence rates, time to return to work or normal function, resource use in terms of number of dressing changes or visits to a nurse, or change in wound size.
There is no high quality evidence for the use of packing for healing perianal abscess cavities.
Assessed as up to date to 17th May 2016.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Packing compared with no packing for perianal abscess cavities Patient or population: patients aged 18 years or over with prim ary perianal abscess Settings: hospital f ollowed by com m unity nursing care Intervention: packing of perianal abscess cavities Comparison: no packing of perianal abscess cavities
Outcomes
Difference in continuous outcomes of participants (studies)
Quality of the evidence (GRADE)
Comments
Packing
No packing (Eisenhammer 1978; Goligher 1984; Hamadani 2009; Nelson 1985; Phillips 1997; Sangwan 1996; Whiteford 2007) .
In the UK, the annual incidence of perianal abscess is estimated to be 40 per 100,000 of the adult population, and acute perianal abscess is the seventh most common emergency condition in general surgery (www.hesonline.gov.uk In the UK, standard surgical drainage involves incising the skin over the abscess in order to drain all the pus and allow wound irrigation. Following drainage, an internal dressing is applied ('packed') to the resulting cavity for haemostasis; that is control of bleeding from the small blood vessels that line the abscess cavity. Common practice in the UK is to continue packing until the abscess cavity has healed (by secondary intention). The pack is changed every day or every few days by community nursing teams. Alternative strategies for managing the abscess cavity have been tried. In the USA and Australia, one variation in the technique for incision and drainage is to use a small stab incision and place a latex catheter (e.g. a 10-14F de Pezzer catheter) into the cavity (Beck 1988; Isbister 1987; Kyle 1990) . This is done under local anaesthetic, unlike practice in the UK, where a general anaesthetic is routinely used. The catheter is cut short and drains into an external dressing. It is removed when it stops draining. In the USA, simple drainage is often performed in an outpatient setting under local anaesthetic (Whiteford 2007). Sewing up (following incision, drainage and curettage) of the abscess cavity with primary sutured closure was first described in 1960 (Ellis 1960) . Primary closure with antibiotic treatment may result in reduced healing times, but the increased incidence of recurrent sepsis negates any benefit (Mortensen 1995). This technique of primary closure is no longer used. Sitz baths (immersing the area in warm water) have been used for treating perianal abscess cavities following incision and drainage. These have been employed both with packing (Read 1979), and without packing (Tang 1996; Vasilevsky 1984) . Although a review of the literature found no benefit for this practice, it makes sense to irrigate an infected wound (Tejirian 2005). Perianal fistulae (fistulae-in-ano) are a complication of perianal abscesses. A fistula may occur if a perianal abscess drains spontaneously through the perianal skin, and if the infection becomes chronic (Parks 1961) . The fistula becomes a tract between the anal canal and the perianal skin that is lined with granulation tissue (present in healing wounds) or skin cells (epithelium). It intermittently discharges pus and may result in recurrent abscesses. Fistulae usually require surgical intervention. This can be at the time of initial abscess drainage (Malik 2010), but usually is performed later. Up to a third of patients with a perianal abscess will develop a fistula (Hamadani 2009; Lohsiriwat 2010; Ramanujam 1984; Vasilevsky 1984) . Following incision and drainage, management of the remaining wound cavity becomes the primary clinical focus to ensure optimal wound closure and prevent recurrence. In the UK, anecdotally, it is common for the cavity to be dressed with an internal dressing (packed) and covered with an external dressing or pad. However, in some other countries, e.g. Germany, use of an internal dressing (packing) is not routinely recommended (Ommer 2012). This review focuses on the impact of internal dressings (packing) on the healing of cavities resulting from the surgical drainage of perianal abscesses.
Description of the intervention
Several dressing types are available to manage perianal abscess cavities; we have summarised the key categories below. There are limited audit type data available on the types of dressings that are used for packing cavities resulting from the drainage of perianal abscesses. Where packing is not used, the wound may just be covered with an external dressing that is not in contact with the cavity itself.
Basic wound contact dressings
Low-adherence dressings and wound contact materials: usually cotton pads that are placed directly in contact with the wound. These can be non-medicated (e.g. paraffin gauze dressing) or medicated (e.g. containing povidone iodine or chlorhexidine). Absorbent dressings: applied directly to the wound or used as secondary absorbent layers in the management of heavily exuding wounds.
Advanced wound dressings
Alginate dressings: highly absorbent dressings made of calcium alginate, or calcium sodium alginate, that may be combined with collagen. The alginate forms a gel when in contact with moisture; this gel can be lifted off when the dressing is removed or rinsed away with sterile saline. Bonding the alginate to a secondary viscose pad increases absorbency. Foam dressings: normally these contain hydrophilic polyurethane foam and are designed to absorb wound exudate and maintain a moist wound environment. There are various versions, and some include additional absorbent materials, such as viscose and acrylate fibres or particles of superabsorbent polyacrylate, which are silicone-coated for non-traumatic removal. Hydrocolloid dressings: these are occlusive dressings usually composed of a hydrocolloid matrix bonded onto a vapour-permeable film or foam backing. When in contact with the moisture at the wound surface this matrix forms a gel to provide a moist environment. Fibrous alternatives have been developed that resemble alginates and are not occlusive, but which are more absorbant than standard hydrocolloid dressings. Capillary action dressings: these consist of an absorbent core of hydrophilic fibres held between two low-adherent contact layers. Odour absorbent dressings: these dressings contain charcoal and are used to absorb wound odour. Often these types of wound dressings are used in conjunction with a secondary dressing to improve absorbency.
How the intervention might work
It is thought that use of an internal dressing (packing) initially aids haemostasis. Continued packing over days to weeks is thought to promote healing by secondary intention, by preventing the wound edges from closing prematurely. It is thought that healing in this way prevents the recurrence of the abscess.
Why it is important to do this review
It is unclear whether packing (compared with not packing) of the cavity following drainage of a perianal abscess is advantageous in promoting healing and preventing adverse events, including fistula formation, abscess recurrence, and wound pain. Anedoctally, the use of packing as a treatment approach in this context varies internationally, and there is limited guidance for practice (Ommer 2012; Steele 2011; Williams 2007) . A German guideline that reported on the diagnosis and treatment of anal abscess stated that regular packing is not required (Ommer 2012), and cited one small trial to support this (Tonkin 2004). Packing has implications for patients and healthcare services: regular changing of internal dressings (change of packing) requires a considerable amount of community nursing time and is, anecdotally, painful for patients. Additionally, the associated healthcare appointments may require patients to take time off work. We believed a transparent and robust review is required to investigate the benefits, harms, and costs of packing (compared with not packing) post-operative perianal abscess cavities, in order to identify, synthesise and report the current evidence base.
O B J E C T I V E S
To assess the effects of internal dressings in healing wound cavities after drainage of perianal abscesses.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We planned to include published and unpublished randomised controlled trials (RCTs; i.e. must be described as randomised in the report), reported in any language, conducted in any country or setting. RCTs reported as conference abstracts would have only been included where there was sufficient information available for data extraction and risk of bias assessment (either from the abstract or from the trial authors). RCTs that used a cross-over design would have been included provided that outcome data were available at the point of cross-over. We would have also included RCTs with cluster randomisation. We would have excluded quasirandomised studies.
Types of participants
Trials recruiting people undergoing surgical drainage of a perianal abscess. We have included studies involving participants of any age, with any underlying aetiological cause for abscess formation.
Types of interventions
Any type of internal dressing (packing) used in the post-operative management of perianal abscess cavities. We have included studies where the presence or absence of an internal dressing (or packing) was the only systematic difference between treatment groups. Comparisons could have included internal dressings compared with no internal dressing; one type of internal dressing compared with another type of internal dressing; or internal dressings compared with non-dressing treatments (for example, topical applications, drainage with a drain rather than an incision).
Types of outcome measures
We have included studies that report one or more of the outcomes below.
Primary outcomes
Wound healing
The primary effectiveness outcome for this review was wound healing. Trialists used a range of different methods of measuring and reporting this outcome. We considered RCTs that reported one or more of the following to provide the most relevant and rigorous measures of wound healing.
• Time to complete wound healing (correctly analysed using survival, time-to-event approaches). Ideally the outcome will have been adjusted (by study authors) for appropriate covariates e.g. baseline ulcer area/duration.
• Proportion of wounds completely healed during follow-up (frequency of complete healing).
We used, and reported, study authors' definitions of wound healing. We reported outcome measures at the latest time point available (assumed to be length of follow-up, if not specified) and the time point specified in the methods as being of primary interest (if this was different from the latest time point available). Where both the outcomes above were reported, we planned to present all data for reference, but to focus on reporting time to healing. When time was analysed as a continuous measure, but it was unclear whether all wounds healed, we documented the use of the outcome in the study, but did not extract, summarise or use the data in a meta-analysis.
Wound pain
• Changes or comparison of validated pain scores, including pain measured on a visual analogue scale (VAS), during treatment or at dressing change, or both.
Secondary outcomes
• Participant health-related quality of life/health status (measured using a standardised generic questionnaire such as EQ-5D, SF-36, SF-12, or SF-6, at noted time points). We have not included ad hoc measures of quality of life that are likely not to be validated and will not be common to multiple trials.
• Frequency of abscess recurrence and fistulae.
• Faecal Incontinence.
• Time to return to work/normal function after perianal abscess incision and drainage.
• Resource use (including measurements of resource use such as number of dressing changes, nurse visits, length of hospital stay and re-operation/intervention).
• Change (and rate of change) in wound size, with adjustment for baseline size (we attempted to contact study authors to request adjusted means when not presented). When change or rate of change in wound size was reported without adjustment for baseline size, we planned to document use of the outcome in the study, but not to extract data, summarise it or use it in any meta-analysis.
Search methods for identification of studies Electronic searches
In May 2016, we searched the following databases to identify reports of relevant clinical trials:
• The Cochrane Wounds Specialised Register (searched 17th May 2016);
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library) (2016, Issue 4);
• . We did not restrict studies with respect to language, date of publication, or study setting. We also searched the following clinical trials registries:
• ClinicalTrials.gov (http://www.clinicaltrials.gov/).
• The World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (http://apps.who.int/ trialsearch/Default.aspx).
• The European Union (EU) Clinical Trials Register (https:// www.clinicaltrialsregister.eu/).
• Japan Registries Network (JPRN) (http://umin.ac.jp).
• Australia and New Zealand Clinical Trials Registry (ANZCTR) (http://www.anzctr.org.au).
Searching other resources
We were keen to explore sources of unpublished data. To maximise identification of unpublished studies, not located during the search stage, we searched the bibliographies of all retrieved and relevant publications identified by these search strategies for further studies. We also examined the content of conference proceedings and systematic reviews in the field that may refer to data we have not found. We contacted key manufacturers (MöInlycke Health Care Ltd, 3M, ConvaTec UK, Aspen Medical Europe Ltd, Syngery Health Plc, Covidien (now Medronic Minimally Invasive Therapies), and Smith and Nephew Plc) to ask about unpublished (as well as ongoing) work. We identified key authors and opinion leaders in the field as those from large research units, editors of colorectal journals, and individuals who had previously published on related subjects and contacted them. We also searched for key abstracts from the following meetings, and requested unpublished data from the authors as required:
• 
Data collection and analysis
Selection of studies
Independently, two review authors (JS and KN) assessed the titles and abstracts of retrieved studies for relevance. After this initial assessment, we obtained full copies of all studies felt to be potentially relevant. Independently, two review authors (KN and JS) checked the full papers for eligibility; disagreements were resolved by discussion and, where required, the input of a third review author (SS). We recorded all reasons for exclusion of studies for which we obtained full copies. A completed PRISMA flowchart summarises this process (Figure 1 
Data extraction and management
We extracted and summarised details of the eligible studies using a data extraction sheet. Two review authors (KN and SS) extracted data independently and resolved disagreements by discussion. Where data were missing from reports, we attempted to contact the study authors to obtain this information. We included studies published in duplicate only once, but extracted the maximal amount of data. Where possible, we extracted date relating to:
• country of origin;
• participants' type and location of abscess -where recorded;
• unit of randomisation and analysis;
• care setting;
• number of participants randomised to each trial arm;
• eligibility criteria and key baseline participant data;
• details of the intervention regimen received by each group;
• details of any co-interventions;
• primary and secondary outcome(s) (with definitions);
• outcome data for primary and secondary outcomes (by group);
• duration of follow-up;
• number of withdrawals (by group); • adverse events;
• publication status of study; and,
• sources of funding for the trial.
Assessment of risk of bias in included studies
Two review authors (KN and SS) independently assessed each included study for bias using the Cochrane tool for assessing risk of bias (Higgins 2011a). This tool addresses six specific domains, namely sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other issues (e.g. issues with unit of investigation). Please see Appendix 2 for details of the criteria upon which judgements were made. We assessed blinding and completeness of outcome data for each outcome separately. We completed a 'Risk of bias' table for the eligible study. We presented the assessment of risk of bias using a 'Risk of bias' summary figure, which presents all of the judgements in a cross-tabulation of study by entry. This display of internal validity indicates the weight the reader has given the results of each study. We resolved disagreements about risk of bias assessment by discussion. Where possible, when a lack of reported information resulted in a decision of 'unclear', we contacted trial authors for clarification. We classified trials as being at high risk of bias overall if they were rated 'high risk' for any one of three key criteria, namely: randomisation sequence, allocation concealment, and blinded out-come assessment. We note it was unlikely that studies assessed at high risk of bias for the generation of randomisation sequence would be included in the review as they would likely not fulfil the criteria of being a RCT. If insufficient detail relating to the conduct of the study was reported, then we classified the study as 'unclear risk' of bias. We classified studies as 'low risk' of bias when sufficient information relating to randomisation sequence, allocation concealment, and blinding was provided and we judged the methodology to be at low risk of bias. We also considered the potential for performance and measurement bias for each primary and secondary outcome we extracted.
Measures of treatment effect
Where possible, we presented the outcome results for each trial with 95% confidence intervals (CI). We reported estimates for dichotomous outcomes (e.g. healed: yes/no) as risk ratios (RRs). We used the RR rather than odds ratio (OR), since, when event rates are high, as is the case for many trials reporting wound healing, ORs (when interpreted as RRs) can give an inflated impression of the effect size (Deeks 2002). We reported outcomes relating to continuous data (e.g. pain) as mean differences (MDs) and overall effect size (with 95% CI). Where treatment outcomes are measured in different ways, we calculated the standardised mean, correcting for direction of scale as appropriate. Where a study reported time to healing data (the probability of healing over a consecutive time period), we planned to report and plot this data (where possible) using hazard ratio estimates.
Unit of analysis issues
We anticipated that most participants would only have one abscess being operated on. For abscess healing, unless otherwise stated, where the number of abscesses appeared to equal the number of participants, we treated the participant as the unit of analysis. However, on occasions where multiple abscesses on a participant had been assessed, we planned to record whether this had been accounted for in the analyses. Where data from cluster-randomised trials are included in the review we planned to adjust for cluster (as the unit of analysis) using a design effect (where possible) (Higgins 2011b). For adverse event outcomes, in order to facilitate further analyses, we planned to establish whether data were presented at the level of the participant, because there is potential for data to refer to multiple events occurring to a single abscess (person), which means that the data cannot be analysed further without violating the assumption of independence.
Dealing with missing data
The problem of missing data is common in trial reports. Excluding participants from the analysis post-randomisation or ignoring those participants lost to follow-up can, in effect, compromise the process of randomisation, and thus, potentially introduce bias into the trial. In individual studies, where data on the proportion of wounds healed were presented, we assumed that, if randomised participants were not included in an analysis, their wounds did not heal (i.e. they were considered in the denominator but not the numerator). Where a trial did not specify participant group numbers prior to dropout, we planned to present only complete case data. In a time-to-healing analysis using survival analysis methods, dropouts should be accounted for as censored data. Hence, all participants should contribute to the analysis. We planned to present data for area change, and for all secondary outcomes, as a complete case analysis. Where there was no measure of variance for a continuous outcome, and no response from the authors, we planned to impute standard deviations/standard errors where possible. If such calculations were not possible, we anticipated that we would be unable to analyse or pool the relevant data.
Assessment of heterogeneity
We considered both clinical and statistical heterogeneity. Wherever appropriate, that is where studies appeared similar in terms of abscess type, intervention type, duration, and outcome type, we pooled data using meta-analysis, conducted using Review Manager 5 (RevMan 2014). As well as exploring clinical and methodological heterogeneity, we assessed statistical heterogeneity using the Chi² test (we considered a significance level of P less than 0.1 to indicate statistically significant heterogeneity) and the I² estimate (Higgins 2003) . The I² estimate examines the percentage of total variation across studies due to heterogeneity, rather than to chance. Values of I² over 50% indicate a moderate level of heterogeneity, and values over 75% indicate a high level of heterogeneity (Higgins  2003) .
Data synthesis
We combined studies using a narrative overview and conducted meta-analyses of outcome data where appropriate (in Review Manager 5; RevMan 2014). The decision to include studies in a metaanalysis depended on the availability of treatment effect data and assessment of heterogeneity. If it was decided to undertake metaanalysis in the presence of clinical heterogeneity (review author judgement) or evidence of statistical heterogeneity, or both, we planned to use the random-effects model. We planned to use a fixed-effect approach only when clinical heterogeneity was thought to be minimal and statistical heterogeneity was estimated as nonstatistically significant for the Chi² value and 0% for the I² assessment (Kontopantelis 2013). For time-to-event data, we planned to use the inverse variance method on the estimated hazard ratio and standard error, when reported (or calculated from reported data if possible).
'Summary of findings' table
We presented the main results of the review in a 'Summary of findings' table. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of available data for the main outcomes (Schunemann 2011a). The 'Summary of findings' table also includes an overall grading of the evidence related to each of the main outcomes using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) approach. The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect, or association, is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of withintrial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates, and risk of publication bias (Schunemann 2011b). We presented the following outcomes in the 'Summary of findings' table.
• Time to wound healing • Wound pain.
Where data were not pooled, we presented a GRADE assessment without a 'Summary of findings' table.
Subgroup analysis and investigation of heterogeneity
If data had been available, potential subgroup analyses planned were:
• underlying aetiological cause, e.g. cryptoglandular disease, Crohn's disease, immunosuppression, trauma, sexually transmitted infection;
• anatomical classification of abscess, e.g. horseshoe abscess (where abscess originates on one side of the perianal region and crosses the midline); and
• participant population age, e.g. under 18 years of age and over 18 years of age.
Sensitivity analysis
If possible, we planned to undertake a sensitivity analysis to investigate the effects of removing studies classed as being at high risk of selection, performance, detection, or attrition bias from the analysis.
R E S U L T S
Description of studies
Results of the search
See Figure 1 for a summary of results of our search.
The search returned 742 citations. After screening, we attempted to retrieve 40 full-texts pertaining to 36 studies potentially relevant to the review (three articles were review articles: Fitch 2007, Milne 2010, and Barnes 1988; and one study had two citations: Cooper 1995). Of these, we excluded 34 studies and included two studies. We also contacted six opinion leaders who had no studies to add to those identified. We contacted seven dressing manufacturers. Only two responded, and they had no studies to add to those identified. A search of trials registries resulted in 10 potential additional studies, of which we excluded three at the screening stage, based upon available information. We obtained further details from study investigators in two cases, and excluded these studies as they do not include perianal abscesses (Myers 2015), or the comparator intervention being investigated was not a dressing (Gustafsson 2015) . Three studies were published, of which we excluded two from the review (Edino 2001; Singer 2013) and included one (Perera 2015). Two studies are ongoing and we have recorded these as awaiting assessment (NCT02286479; NCT01897675).
Included studies
See Characteristics of included studies tables for a summary of the included studies. This review included two studies, both were conducted in single centres, one in Australia (Tonkin 2004), and one in the UK (Perera 2015). Both studies included participants aged 18 years or over with an anorectal (perianal) abscess. Both studies excluded participants with abscesses secondary to another cause, such as Crohn's disease, those requiring a second operation for undrained sepsis, and those unable to give consent. Perera 2015 also excluded participants who had a fistula detected at operation, unlike Tonkin 2004 who treated the fistula at operation and included the participants in the study. The included studies were both small (Perera 2015: n = 14; and Tonkin 2004: n = 50) with similar study designs randomising participants to packing or non-packing of their perianal abscess. Tonkin 2004 gave some details as to the surgical technique: all participants had their abscess incised and drained using an elliptical incision to "deroof " the cavity and a pack was inserted for haemostasis. Perera 2015 only describes incision and drainage under general anaesthesia with insertion of a haemostatic pack. In both studies, participants were enrolled to the study on the first post-operative day and randomised to continued packing by community district nursing teams or no packing. Participants in the non-packing group managed their own wounds in the community. In Tonkin 2004, absorbant dressings were used to cover the area. In both studies, fortnightly follow-up was undertaken until the cavity was closed and the skin re-epithelialised, which constituted healing. In Perera 2015, the minimum follow-up was six months to establish whether abscess recurrence had occurred. In both studies, telephone follow-up was conducted for non-attenders. Outcomes of interest reported in both studies were wound healing, wound pain, fistula formation, and abscess recurrence.
Excluded studies
See Characteristics of excluded studies tables for a summary of the excluded studies. Of the 40 full-text articles we retrieved, three were review articles and one study had two citations. Of the 36 studies remaining, we excluded 34 studies at the full-text stage, including two studies for which full-text articles were not available (Edino 2001; Meng 2005) .
One study was only published in abstract form and the authors were not contactable (Gibson 1994) . Eight studies were non-randomised (Beck 1988; Gajiwala 2006; Guest 2005; Isbister 1987; Kyle 1990; Lundhus 1993; Ritchie 1972; Wilson 1964) . One study had an irrelevant intervention (Llera 1985) . Three studies included packing versus a group with multiple different interventions, making analysis of the lack of packing impossible (Kronborg 1984; Leaper 1976; Sørensen 1987) . Ten studies included abscesses on multiple sites of the body, and it was not possible to get subgroup analyses for the participants with perianal abscesses (Abraham 1997; Alimov 2013; Dawson 1992; Gupta 1992; Macfie 1977; Moore 2000; Simms 1982; Stewart 1985; Williams 1995; Wu 2008) . Nine studies included abscesses on multiple sites of the body, but did not include perianal abscesses (Berry 1993; Butterworth 1991; Cooper 1995; Kessler 2012; Koehler 2009; O'Malley 2009; Singer 2013; Ubbink 2008; Young 1982) .
Risk of bias in included studies
See Characteristics of included studies for risk of bias data for the included study, and Figure 2 for the risk of bias summary, for the included studies.
Figure 2. Risk of bias summary: review authors' judgements about each risk of bias item for the included study.
Allocation
Tonkin 2004 gave no information as to how the randomisation sequence was generated. Allocation was undertaken using sealed envelopes but it was not clear whether these were numbered. Consquently, we classed the study as being at unclear risk of selection bias. Perera 2015 utilised a computer-generated randomisation sequence which is considered at low risk of bias, but, again, the allocation was conducted using sealed envelopes and it was not clear whether these were numbered. We therefore, classed this study as being at unclear risk of selection bias.
Blinding
There is no record of the use of blinding in either study. Tonkin 2004 recruited post-operatively, so there is unlikely to be risk of bias in the operative technique. Tonkin 2004 does not comment on the use of blinding, and this may have resulted in detection bias. We deemed this study as having an unclear risk of detection bias. Perera 2015 recruited the majority of participants post-operatively and it is unclear if this has had an impact on bias. Perera 2015 did not blind participants or investigators due to the nature of the intervention, which could result in detection bias. We deemed this study at high risk of detection and performance bias.
Incomplete outcome data
Tonkin 2004 lost seven participants to follow-up (three in the packing group and four in the non-packing group). This represents 14% of the study population. It was considered to have substantial impact on the results and was deemed to be at high risk of attrition bias. Perera 2015 did not lose any participants to follow-up. No participants withdrew and no intervention was discontinued. All follow-up conducted in person and no adverse events occurred. We considered the study to be at low risk of attrition bias.
Selective reporting
Both studies reported all outcomes recorded in the trial methods, but the protocols were not scrutinised. We deemed the studies to be at low risk of reporting bias.
Other potential sources of bias
Tonkin 2004 followed participants up fortnightly until healed. However, one participant is described as taking more than 12 months to heal, and appears to have been omitted from the analysis. The effect of this bias is unclear.
Effects of interventions
See: Summary of findings for the main comparison Summary of Findings Table  Comparison 1 : Packing compared with no packing in patients with perianal abscesses (2 trials; 64 participants) Primary outcome: Time to complete wound healing Tonkin 2004 reports a median time to healing of 24.5 days (range 10 to 150 days) in the packing group and 21.0 days (range 8 to 90 days) in the non-packing group. The study authors report that the difference was not statistically significant (P = 0.214) but their methods note that the Mann-Whitney U test has been used for the analysis. This does not take censoring into account and is not the most appropriate statistical method to use. Based on available data we have not been able to re-analyse the study. GRADE assessment: Very low quality evidence; downgraded one level for serious limitation (attrition bias), serious indirectnesswe were unable to assess the time to healing data fully, given data and analyses presented. We also downgraded two levels for very serious imprecision as this was a small study (n=50), but since 95% confidence intervals (CIs) around the treatment effect were not presented, the impact of this could not fully be assessed. Risk of bias for this study was unclear due to poor reporting. Perera 2015 reported a mean time to healing of 26.8 days (95% CI 22.7 to 30.7) in the packing group and 19.5 days (95% CI 13.6 to 25.4) in the non-packed group (it was not clear whether all participants healed). A log rank test was used for the analysis and the time to healing was reported to be reduced in the nonpacking group compared to the packing group (P = 0.047). We re-analysed the data and found no clear difference in the time to healing (7.30 days, 95% CI -2.24 to 16.84; participants = 14) Analysis 1.1. GRADE assessment: Very low quality evidence; downgraded two levels for imprecision as this was a very small study (n=14), and one level for limitations in the design as there is a lack of blinding, which is likely to result in performance and detection bias. We have not assessed the proportion of wounds completely healed during follow-up as this was not reported in either study.
Primary outcome: Wound pain
Both studies recorded pain scores with a 10 cm visual analogue scale (VAS). Traditionally, the VAS has word descriptors at each end, for instance "no pain" and "very severe pain." The participant marks on the line where they think their pain is between those two points. This mark is then measured from the "no pain" descriptor. It is standard that the higher the score, the worse the pain.
Although neither study has confirmed that they used the VAS in this way, we have assumed that they have adopted the standard reporting technique. Tonkin 2004 reported median VAS pain scores as 8 in the packing group compared to 4.5 in the non-packing group at the initial dressing change following randomisation (P = 0.296). Perera 2015 reported median VAS pain scores as 3 (interquartile range (IQR) = 6) in the packing group compared to 2 (IQR = 4.5) in the nonpacking group at the initial dressing change following randomisation (P = 0.648). In both studies, the authors report that this difference was not statistically significant. We have not been able to reproduce these analyses, since variation data, such as the standard error or the standard deviation, were not presented. At two weeks, both studies asked participants for a retrospective judgement of pain recorded on a VAS for the overall pain in that time period. However, it is not clear if this time period was two weeks following randomisation or surgery. Tonkin 2004 reported a median VAS score of 2 for the packing group and 0 for the nonpacking group. This was reported by the study authors as being statistically significant (P = 0.004) but again no further details are presented and data are not presented in a way that we are able to conduct our own analysis of the aggregate data. Perera 2015 reported a statistically significant (P = 0.030) median VAS score of less pain in the non-packing group (0, IQR = 1) compared to the packing group (2, IQR = 3). GRADE assessment: Very low quality evidence; downgraded one level for indirectness -we were unable to re-create analyses, given the data and analyses presented. We also downgraded two levels for imprecision as this was a small study, but since 95% CIs around the treatment effect were not presented the impact of this could not fully be assessed and once for limitations in the design due to attrition bias and lack of blinding, which is likely to result in performance and detection bias.
Secondary outcome: Fistula formation
There was no clear evidence of a difference in the number of postoperative fistulae that formed between the study groups in either study.
Tonkin 2004 reported 4/20 (20.0%) in the packing group compared with 2/23 (8.7%) in the non-packing group during the variable follow-up period (participants were followed up until they were healed): risk ratio (RR) 2.30, 95% CIs 0.47 to 11.26 (Analysis 1.2). The estimate is very imprecise with CIs ranging from a reduction in risk of 53% to an increase risk of 1126%. Perera 2015 reported 1/8 (12.5%) post-operative fistulae in the packing group compared with 0/6 (0%) in the non-packing group during the variable follow-up period (participants were followed up until they were healed or for six months at a minimum): RR 2.33, 95% CIs 0.11 to 48.99 (Analysis 1.2) . The estimate is extremely imprecise with CIs ranging from a reduction in risk of 89% to an increase in risk of 4899%. Given the clinical and methodological similarities, we pooled the data and the I 2 metric returned was 0% (Analysis 1.2). There was no clear evidence of a difference in post-operative fistulae between groups: RR 2.31, 95% CIs 0.56 to 9.45. However, even pooling the data, the sample size remained very small and the estimate was very imprecise.
Grade assessment: Very low quality evidence. Downgraded three levels for very serious imprecision as these were small studies and serious limitations in the design due to attrition bias and lack of blinding, which is likely to result in performance and detection bias.
Secondary outcome: Recurrence of abscess
There was no clear evidence of a difference in the number of abscess recurrences between the study groups over the variable followup period in either study. Tonkin 2004 reported 1/20 (5.0%) in the packing group compared with 3/23 (13.0%) in the nonpacking group: RR 0.38, 95% CIs 0.04 to 3.40 (Analysis 1.3) . This estimate is very imprecise with CIs ranging from a reduction in risk of abscess recurrence in the packing group of 96% to an increased risk of 340%. Perera 2015 reported 3/8 (37.5%) abscess recurrences in the packing group compared with 2/6 (33.3%) in the non-packing group: RR 1.13, 95% CIs 0.27 to 4.76 (Analysis 1.3). This estimate is very imprecise with CIs ranging from a reduction in risk of 73% of abscess recurrence in the packing group to an increased risk of 476%.
Given the clinical and methodological similarities, we pooled the data and the I 2 metric returned was 0% (Analysis 1.3). There was no clear evidence of a difference in abscess recurrence groups: RR 0.72, 95% CI 0.22 to 2.37. However, even pooling the data, the sample size remained very small and the estimate was very imprecise.
Grade assessment: Very low quality evidence. Downgraded three levels for very serious imprecision as these were small studies and serious limitations in the design due to attrition bias and lack of blinding, which is likely to result in performance and detection bias. Secondary outcome: resource use (hospital stay) Tonkin 2004 described the length of hospital stay as "one" in each group. We assume this to mean one day as no units are given for this. The authors report a P value of 0.479 for a Mann-Whitney U statistical comparison between the study groups, but not enough data has been presented for us to synthesise an analysis. There is no clear evidence of a difference between the study groups. Perera 2015 discharged all participants on day 1 post-operatively.
Other secondary outcomes
Unfortunately, we did not find any randomised controlled trials (RCTs) that compared participant health-related quality of life/ health status, incontinence rates, time to return to work or normal function, resource use in terms of number of dressing changes or visits to a nurse, or change in wound size.
D I S C U S S I O N
Summary of main results
Data from two studies (n = 64) compared packing (standard care with internal dressing) with no packing (no internal dressing) for the treatment of perianal abscess cavities. Due to the variation in reporting of the time to complete wound healing outcome we were unable to pool data and it was difficult to draw conclusions about the impact of packing on time to complete wound healing. In Tonkin 2004, data were not analysed or presented in a way where variation around the estimates could be assessed. Perera 2015 reported that there was a reduction in time to healing in the non-packing group when the log rank test was applied, but on further analysis of the data we regarded this difference as not statistically significant. Study authors reported pain data in ways which meant we could not use or re-analyse it. We cannot therefore draw any conclusions regarding the difference in the amount and duration of pain experienced between packing and no packing, although it would be very surprising if there were no difference. It is unclear whether packing influences the number of post-operative fistulae, abscess recurrences or length of hospital stay.
Overall completeness and applicability of evidence
The use of internal dressings (packing) compared with no packing for healing perianal abscesses has only been evaluated in two very small randomised controlled trials (RCTs). This results in very limited evidence.
Quality of the evidence
Overall, the evidence was of very low quality with generally unclear or imprecise estimates. The studies were very small and Tonkin 2004 appeared to remove participants from the analysis. Both studies were underpowered to detect differences in the number of post-operative fistulae formed and number of abscess recurrences. The authors of Tonkin 2004 have calculated that to detect a difference of 10% in fistulae and abscess recurrence rates, 316 participants would be needed whilst they only included 50. The presentation of time-to-event data made it difficult to interpret and present here. We were concerned that Tonkin 2004 may have analysed time-to-event data with an inappropriate statistical test and there is not enough data reported for re-analysis. Ideally, time-to-event data are summarised using the median, and presented as a hazard ratio with variance data. Appropriate statistical tests, such as the log rank test, should be applied. It is also useful to present the total number of events that occurred in each group, both as useful data, and to aid potential meta-analysis of time-toevent data. It is also important to note that in Perera 2015 blinding was not used and in Tonkin 2004 there is no report of the use of blinding, especially in relation to blinded outcome assessment. Since assess-ment of wound healing has a subjective element, the use of blinded outcome assessment in such trials would be recommended. Given the lack of reported methodological information in Tonkin 2004, we assessed the risk of detection bias as unclear, as we did selection bias. Overall, clearer reporting of trial methods would have enabled us to class risk of bias domains more usefully as high or low risk. We downgraded Perera 2015 three times due to indirectness, imprecision, and limitations in design and we classed this study at high risk of detection and performance bias.
Potential biases in the review process
The review considered as much evidence as it was possible to obtain, including studies that were not published in English. It was not possible to obtain two papers; these studies included abscesses on multiple regions of the body and were unlikely to yield significant subgroup data for perianal abscesses. A further study was only published in abstract form and it was not possible to scrutinise the data further.
Agreements and disagreements with other studies or reviews
There are no other systematic reviews of RCTs relating to packing of perianal abscesses. All the available RCTs to date have been scrutinised for this review.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
There is no good quality evidence for the use of internal dressings (packing) for healing perianal abscess cavities, and yet, this is established, common practice (Nelson 2002) . This review has found only two small randomised controlled trials (RCTs) which together provide very low quality evidence due to attrition, performance, and detection bias, as well as imprecision (small studies) and indirectness. Fistula formation rates, with and without packing, are not known. Given the current lack of evidence, decisions to pack may be based on local practices.
Implications for research
Further research to evaluate the healing rates by not packing perianal abscess cavities, and the potential benefit to patients of decreased wound pain is needed, alongside assessment of the safety of not packing in terms of fistula formation and abscess recurrence rates. Large, appropriately powered, robust RCTs comparing packing versus not packing of perianal abscess cavities would be the most appropriate study design, with the study population
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Perera 2015
Methods Two-arm randomised controlled trial with randomisation of 'the majority of participants' after first dressing change Single centre in UK Duration of follow-up was fortnightly until healing had occurred or a minimum of 6 months or if a recurrent abscess or fistula formed Participants Number of participants randomised = 14 Number of participants analysed = 14 Inclusion criteria:
• participants aged > 18 years with an anorectal abscess Exclusion criteria:
• participants aged < 18 years • participants with abscesses associated with Crohn's disease or other underlying causes, including known fistulae
• abscesses in which initial drainage was considered inadequate • participants unable to give informed consent Baseline details: 63% (5/8) of participants were male in the packing group and 33% (2/6) in the nonpacking group Median age was 47 years (IQR = 17) in the packing group and 48 years (IQR = 7) in the non-packing group Median duration of symptoms: 4 days in packing group, 6 days in non-packing group Abscesses were classified as superficial or deep, although no details are given on how this classification has been made. 37.5% were classified by study authors as deep in the packing groups and 33.3% in the non-packing group Median incision size was 30 mm (IQR = 15) in the packing group and 30 mm (IQR = 17.5) in the non-packing group
Interventions
Both groups underwent incision and drainage under general anaesthetic. No operative details are given, except noting that a haemostatic pack was placed at the end of the operation Randomisation on day 1 post-operatively Packing group: dressing changed in hospital on day 1 and care transferred to community nursing teams for daily dressings in their own home (n = 8) Non-packing group: dressing removed on day 1 in hospital and superficial protective/ absorptive dressing applied. No community nursing team involvement (n = 6) Outcomes Primary outcome: median time to healing (defined as complete re-epithelialisation of the wound) Secondary outcomes:
• median pain scores • post-operative fistula formation • abscess recurrence Perera 2015 (Continued)
Notes
Funding source: no funding used for the study
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias)
Low risk Quote: "Patients were randomly assigned to receive either packing or no packing through allocation by sealed envelope derived from a computer-generated randomisation sequence, which was carried out by a member of the study team" Comment: Computer-generated randomisation sequence
Allocation concealment (selection bias) Unclear risk Quote: "Patients were randomly assigned to receive either packing or no packing through allocation by sealed envelope derived from a computer-generated randomisation sequence, which was carried out by a member of the study team" Comment: Lack of detail on whether envelopes were numbered and sequentially ordered to ensure adequate allocation concealment
Blinding of participants and personnel (performance bias) All outcomes High risk Quote: "Due to the nature of the intervention, it was not possible for the participants or the investigators to be blinded" Comment: Blinding was not feasible, therefore study at high risk of bias Other bias Unclear risk Quote: "The majority of patient recruitment was performed postoperatively following incision and drainage, and prior to any dressing change" Comment: Unclear how many patients were recruited pre-operatively or the impact of this
Tonkin 2004
Methods Two-arm randomised controlled trial with randomisation after first dressing change Single centre in Australia Duration of follow-up was fortnightly until healing had occurred or a recurrent abscess or fistula formed Participants Number of participants randomised = 50 Number of participants analysed = 43 (7 lost to follow-up) Inclusion criteria:
• participants aged < 18 years • participants with abscesses associated with Crohn's disease or other underlying causes
• abscesses in which initial drainage was considered inadequate • participants unable to give informed consent Baseline details: 85% of participants were male in the packing group and 78% in the non-packing group The median age was 33 years in both groups (range 21-58 in packing group, 19-65 in the non-packing group) Abscesses were classified as superficial (submucosal) or deep (ischiorectal/intersphincteric). Both groups had 7 deep abscesses Median abscess size was 30 mm in each group and there were no significant differences between the groups in the location of the abscess Median duration of symptoms: 4 days in packing group, 3 days in non-packing group Fistula laid open at initial operation in 6 participants: 2 in packing group, 4 in nonpacking group. One fistula in packing group detected at operation but is unaccounted for in the trial report Length of hospital stay was a median of 1 day in both groups
Interventions
Both Unclear risk Quote: "On the first post-operative day... patients were provided with written information on the trial protocol, and informed written consent was obtained. Patients were then randomised to packing and nonpacking groups using a sealed envelope system" Comment: No information on how randomisation sequence was generated Allocation concealment (selection bias) Unclear risk Quote: "On the first post-operative day, before any change of dressing, patients who fulfilled the inclusion criteria were invited to enrol in the study...Patients were then randomised to packing and nonpacking groups using a sealed envelope system" Comment: Lack of detail on whether envelopes were numbered and sequentially ordered to ensure adequate allocation concealment Total events: 4 (Packing), 5 (Non-packing)
Heterogeneity: Chi 2 = 0.69, df = 1 (P = 0.41); I 2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59) Test for subgroup differences: Not applicable 0.1 0.2 0.5 1 2 5 10
Favours non-packing Favours packing
Blinding of participants/care providers/outcome assessors -was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following:
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others is unlikely to introduce bias.
High risk of bias
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others is likely to introduce bias.
Unclear risk of bias
Either of the following:
• Insufficient information provided to permit judgement of low or high risk of bias.
• The study did not address this outcome.
Were incomplete outcome data adequately addressed?
Low risk of bias
• No missing outcome data.
• Reasons for missing outcome data are unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).
• Missing outcome data are balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is not enough to have a clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, a plausible effect size (difference in means or standardised difference in means) among missing outcomes is not enough to have a clinically relevant impact on the observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
• Reason for missing outcome data are likely to be related to the true outcome, with either an imbalance in numbers or reasons for missing data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with the observed event risk is enough to induce clinically relevant bias in the intervention effect estimate.
• For continuous outcome data, a plausible effect size (difference in means or standardised difference in means) among missing outcomes is enough to induce clinically relevant bias in the observed effect size.
• 'As-treated' analysis is done with a substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
